NalaGenetics' “Preventive Healthcare” Innovation and Its Potential to Revolutionize Healthcare
DailySocial.id interview with NalaGenetics Co-Founder & COO Astrid Irwanto discusses the potential, challenges and future of genomic innovation in the health industry
NalaGenetics is a startup Biotech which seeks to revolutionize healthcare through innovation in the field of genomics. Through their affordable DNA testing services, they strive to empower every individual to make the right decisions for their health. This includes providing personalized recommendations about nutritional and medication choices according to the body's genetics.
Based on the DNA test results data, NalaGenetics' services continue to be expanded. Recently their capabilities were expanded by producing a breast cancer risk prediction test called MammoReady --- rated as the most comprehensive in Southeast Asia. This is a very important innovation in the medical world, because by early detection of cancer, survivors can have a survival rate of up to 98%.
As is known, from Globocan data as quoted Ministry of Health, in 2020 the number of new cases of breast cancer was recorded at 68.858 cases (16,6%) out of a total of 396.914 new cases of cancer in Indonesia. The death toll reached more than 22 thousand people. This figure makes this disease one of the highest contributors to death in Indonesia.
Not ready to subscribe yet? Purchase and access this article